Fenetylline: therapeutic use, misuse and/or abuse
- PMID: 3743408
- DOI: 10.1016/0376-8716(86)90012-8
Fenetylline: therapeutic use, misuse and/or abuse
Abstract
Fenetylline (CAPTAGON) is included in a list of compounds to be considered by a World Health Organization (WHO) Expert Committee in April 1985 for possible international scheduling under the Convention on Psychotropic Substances, 1971. For over 23 years, this central stimulant has been used therapeutically in hyperkinetic children and other indications in place of amphetamines and other central stimulants with higher risk levels. In good correspondence with recent animal data fenetylline also shows significant qualitative and quantitative differences compared to amphetamine in man. It has few adverse side effects, a lower abuse potential and little actual abuse compared to amphetamine. Thus its benefit/risk assessment is substantially more favourable than that of other central stimulants. For proper therapeutic use of the substance, prescription status is or should be required by national authorities.
Similar articles
-
Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO.Drug Alcohol Depend. 1986 Jun;17(2-3):169-92. doi: 10.1016/0376-8716(86)90007-4. Drug Alcohol Depend. 1986. PMID: 2874968
-
[Treatment of attention deficit disorders in adulthood using psychostimulants and low-dose neuroleptics--a critical case report].Psychiatr Prax. 1988 Mar;15(2):62-5. Psychiatr Prax. 1988. PMID: 2898788 German.
-
Potential adverse effects of amphetamine treatment on brain and behavior: a review.Mol Psychiatry. 2009 Feb;14(2):123-42. doi: 10.1038/mp.2008.90. Epub 2008 Aug 12. Mol Psychiatry. 2009. PMID: 18698321 Free PMC article. Review.
-
Fenethylline (Captagon) Abuse - Local Problems from an Old Drug Become Universal.Basic Clin Pharmacol Toxicol. 2016 Aug;119(2):133-40. doi: 10.1111/bcpt.12584. Epub 2016 Apr 8. Basic Clin Pharmacol Toxicol. 2016. PMID: 27004621 Review.
-
Mefenorex (Rondimen).Drug Alcohol Depend. 1986 Jun;17(2-3):229-34. doi: 10.1016/0376-8716(86)90010-4. Drug Alcohol Depend. 1986. PMID: 3743406
Cited by
-
Insight of Captagon Abuse by Chemogenomics Knowledgebase-guided Systems Pharmacology Target Mapping Analyses.Sci Rep. 2019 Feb 19;9(1):2268. doi: 10.1038/s41598-018-35449-6. Sci Rep. 2019. PMID: 30783122 Free PMC article.
-
Moral and social reasons to acknowledge the use of cognitive enhancers in competitive-selective contexts.BMC Med Ethics. 2016 Mar 29;17:18. doi: 10.1186/s12910-016-0102-8. BMC Med Ethics. 2016. PMID: 27025299 Free PMC article.
-
The Emergence of the Old Drug Captagon as a New Illicit Drug: A Narrative Review.Cureus. 2024 Feb 27;16(2):e55053. doi: 10.7759/cureus.55053. eCollection 2024 Feb. Cureus. 2024. PMID: 38550445 Free PMC article. Review.
-
Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA).Br J Pharmacol. 2008 Jun;154(3):606-22. doi: 10.1038/bjp.2008.124. Br J Pharmacol. 2008. PMID: 18500382 Free PMC article. Review.
-
Pharmacoterrorism: the potential role of psychoactive drugs in the Paris and Tunisian attacks.Psychopharmacology (Berl). 2016 Mar;233(6):933-5. doi: 10.1007/s00213-016-4204-2. Epub 2016 Jan 11. Psychopharmacology (Berl). 2016. PMID: 26750118 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous